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A B S T R A C T
Electronic-cigarettes (e-cigarette) are widely used as an alternative to traditional cigarettes but their safety is not
well established. Herein, we demonstrate and validate an analytical method to discriminate the deleterious
eﬀects of e-cigarette reﬁlls (e-juice) and soluble e-juice aerosol (SEA) by employing stress-speciﬁc biolumines-
cent recombinant bacterial cells (RBCs) as whole-cell biosensors. These RBCs carry luxCDABE-operon tightly
controlled by promoters that speciﬁcally induced to DNA damage (recA), superoxide radicals (sodA), heavy
metals (copA) and membrane damage (oprF). The responses of the RBCs following exposure to various
concentrations of e-juice/SEA was recorded in real-time that showed dose-dependent stress speciﬁc-responses
against both the e-juice and vaporized e-juice aerosols produced by the e-cigarette. We also established that high
doses of e-juice (4-folds diluted) lead to cell death by repressing the cellular machinery responsible for repairing
DNA-damage, superoxide toxicity, ion homeostasis and membrane damage. SEA also caused the cellular
damages but the cells showed enhanced bioluminescence expression without signiﬁcant growth inhibition,
indicating that the cells activated their global defense system to repair these damages. DNA fragmentation assay
also revealed the disintegration of total cellular DNA at sub-toxic doses of e-juice. Despite their state of matter,
the e-juice and its aerosols induce cytotoxicity and alter normal cellular functions, respectively that raises
concerns on use of e-cigarettes as alternative to traditional cigarette. The ability of RBCs in detecting both
harmful eﬀects and toxicity mechanisms provided a fundamental understanding of biological response to e-juice
and aerosols.
1. Introduction
The electronic cigarettes (e-cigarettes) are powered by battery-
devices which uses the generated heat energy to transform the e-juice
into the vapours that mimic the ordinary hand-to-mouth sensory
experience of smoking to the user. The e-juice is a solution of nicotine
in a mixture of glycerin, polyethylene or polypropylene glycol and
ﬂavoring additives (Brandon et al., 2015). The e-cigarettes are believed
to be comparatively less harmful as well as an alternative to conven-
tional smoking (Harrell et al., 2015). Therefore, e-cigarettes are
progressively gaining popularity and prevalence in delivering vaporized
nicotine (Allen et al., 2016). Howover, recent studies documented the
toxic eﬀects of e-juice on the human embryonic stem cells, human
pulmonary ﬁbroblasts cells and mouse neural stem cells (Bahl et al.,
2012; Lerner et al., 2015). Moreover, the e-cigarette aerosols or e-
vapours were also documented to be toxic to primary human bronchial
epithelial cells (Scheﬄer et al., 2015) and human gingival ﬁbroblasts
(Sancilio et al., 2016) upon direct exposure. It is imperative to develop
new in vitro techniques for rapid screening of cytotoxicity or genotoxic
hazards of e-juice and its e-vapours, especially when new brands of e-
cigarettes being progressively introduced into the market (Chu et al.,
2015). The cartridges used to reﬁll the e-cigarette have been detected
with contaminants, such as diethylene glycol, heavy metals, silicate
particles, and potential carcinogens, such as nitrosamines (Cheng,
2014; Orellana-Barrios et al., 2015; Williams and Talbot, 2011).
Additionally, nicotine, also the main ingredient of e-cigarette known
to produce reactive oxygen species (ROS) that trigger antioxidant
imbalance and ROS-induced oxidative DNA damage in rat cells
(Muthukumaran et al., 2008). Likewise, e-juice aerosols generated
after heating in e-cigarette also contributes to ROS generation in cells
(Lerner et al., 2015; Scheﬄer et al., 2015). Oxidative DNA damages by
ROS, such as superoxide anion radicals (•O2
−), hydrogen peroxide
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(H2O2) and hydroxyl radicals (
•OH) induce mutations, breaks in DNA
strands and lesions causing various diseases including cancer (D'Errico
et al., 2008).
Considering the limited knowledge of health impacts of e-cigarettes,
it is imperative to explore its potential impact on living cells.
Recombinant Bacterial Cells (RBCs) can be used as living biosensors
to rapidly evaluate and analyse the toxicity of e-juice/liquids and
associated e-aerosols (e-vapours) at their sub-toxic concentrations. The
RBCs harbour a reporter operon which is strictly governed by the
transcriptional regulating promoters speciﬁc to target chemical/agent
that generate an output signal in the form of light or color. Such
biological sensors provide a cost eﬀective, rapid, easy and alternative
means to assess speciﬁc toxicity modes of target chemicals, such as
those present in the e-juice. This type of biosensors has been used for
long in various biosensing experiments (He et al., 2016). For instance,
recA promoter is transcriptionally fused with the green ﬂuorescence
protein gene (GFP) to screen the bacterial DNA inhibitors via the SOS
response (Fan et al., 2014), and sodA regulating GFP is used in
bioassays for drug screening (Elad et al., 2015).
In this study, we have investigated the toxicity of e-juice and its
aerosols at sub-toxic doses by employing four distinct stress-speciﬁc
RBCs as biosensors. These bacterial biosensors emit light by expressing
stress-speciﬁc promoters upstream of Photorhabdus luminescens
luxCDABE genes present on a plasmid in recombinant E. coli against
cellular damages, such as DNA damage, oxidative stress by superoxide
radical, heavy metals (copper) and membrane damage. The light
emission responses against the chemical stimuli in RBCs is the
signature of toxicity in cells and the speciﬁc promoter provide
information on type cellular damage. Here, sub-toxic stress concentra-
tion of chemicals present in e-juice and aerosols were determined. Our
results demonstrated that the liquid and aerosol forms of e-juice had
distinct impact on living cells. Direct cellular interaction with diluted e-
liquids imposed growth inhibition and repression of genes responsible
for cellular repair mechanism and heavy metal homeostasis. Higher e-
liquid concentrations could lead to total cellular DNA-fragmentation.
However, e-juice in aerosol forms showed no growth inhibition but
induced the genes of cellular repair mechanisms in an eﬀort to mitigate
cellular stress. Such an approach to accessing the toxicity of e-juice and
e-vapours/aerosols could provide ﬁrst information on overall cellular
responses that may be useful for further studies on their toxicity using
human cells.
2. Materials and methods
2.1. Plasmids, bacterial strains and chemicals
The plasmids and stress-inducible bioluminescent recombinant
bacterial cells used in this study are listed in Table S1. All strains were
grown in either synthetic-M9 or LB-broth medium (Difco MI, USA)
depending upon the speciﬁed experimental conditions. The commercial
e-juice (NJOY) was purchased from a local vendor that according to the
manufacturer, contained glycerin, propylene glycol, nicotine (10 mg/
mL) and other ﬂavoring chemicals. All other reagents used were of
analytical grade. The RBCs were designed to speciﬁcally respond to
DNA damage (E. coli-RecA), oxidative toxicity (E. coli-SodA), heavy
metal (E. coli-CopA) and membrane damage (E. coli-DMO1). Fig. 1a-e
shows map of plasmid carried by each RBC that were utilized to screen
the harmful eﬀects of e-juice and SEA.
2.2. Determination of eﬀective concentration at half maximum
toxicity (EC50)
The stress-speciﬁc bioluminescent bacteria and control cells were
treated with a series of e-juice dilutions in M9-medium and EC50 was
determined as described in Supporting information (SI) section.
2.3. Preparation of bubble-solubilized e-juice aerosols
The engineered design and used materials in the e-cigarettes could
also aﬀect the chemical characteristics and potential toxicity of released
e-vapours/aerosols from the e-cigarettes (Brown and Cheng, 2014;
Kosmider et al., 2014). Therefore, in this study we utilized a concen-
tration chamber equipped with an inlet and outlet to collect the
released e-cigarette aerosols (e-vape) by bubble-solubilizing in
synthetic M9-medium (Fig. 1a-b). About, 1.8 mL of concentrated e-
juice reﬁll (10 mg/mL of nicotine+other ingredients) was loaded in the
e-cigarette device and puﬀed through the atomizer into 22.5 mL of
synthetic M9-medium with the help of an inlet tube connected to the
mouthpiece of the device and a vacuum suction at the outlet of the
concentration chamber. Finally, the bubble-solubilized e-cigarette
aerosols (SEA) (0.8 mg/mL with respect to nicotine content) in M9-
medium was further diluted to various dilutions below EC50 levels and
used for toxicity screening with RBCs.
2.4. UV–vis spectra, cell growth and bioluminescence assays
The UV–vis spectra of e-juice in liquid form and SEA were recorded
between 200 and 350 nm using NanoDrop 2000 UV–Vis spectro-
photometer. The sub-toxic to lethal eﬀects of e-juice and SEA (diluted
4–256-folds) were exposed to four stress-speciﬁc bioluminescent
recombinant E. coli cells shown in Table S1. Each strain contained a
plasmid carrying a fusion of promoter and reporter luxCDABE from
Photorhabdus luminescens, where the promoter speciﬁcally responds
to toxicity, such as genotoxicity (recA), heavy metals (copA), super-
oxide stress (sodA) and membrane integrity (oprF) upstream of the
luxCDABE gene cassette (Table SI). The recombinant bacterial strains
carrying recA::luxCDABE, sodA::luxCDABE, copA::luxCDABE and
oprF::luxCDABE were pre-grown in 5 mL of M9–broth media (Difco
MI, USA) for 14 h at 37 °C with constant shaking (120 rpm). The cells
were harvested by centrifugation at 5000 rpm for 10 min and washed
thrice with PBS (pH 7.6). These cells were then re-suspended across
the 96-well white plates with transparent bottom (BRANDplates®) in a
way that allow diﬀerent concentrations of e-juice/SEA present in
100 µL synthetic M9-media with initial absorbance of 0.22 at 600 nm
or ~1.8×108 cells/mL for bioluminescence assays. Besides, culture
media containing no e-juice/SEA were also inoculated under identical
conditions and used as standard controls for comparison. The white
96-well plates with transparent bottom allowed simultaneous measure-
ment of both bioluminescence and absorption at 600 nm in a Synergy
HTX-multimode microplate reader (Biotek) equipped with a photo-
multiplier tube (PMT) to collect whole photons from recombinant
strains and the microplate reader computed the generated signal into
relative arbitrary light units (RLU, bioluminescence). Both absorbance
and bioluminescence of the RBCs were recorded at every 10 min
intervals for 8 h. Other assay controls such as those interfering in the
media and e-juice were taken into consideration and used as appro-
priate blanks for normalization. Moreover, net bioluminescence induc-
tion caused by the model chemicals in RLU was divided by the OD600
to correct for variations in cell density as reported previously (Elad
et al., 2015). All the bioluminescence raw data was subjected to
normalization and histogram and clustering was generated using
clustergram tool in Matlab software.
All assays were conducted in replicates (n=3) and normalized with
appropriate assay controls and the % relative standard deviations (%
RSD) was calculated to be less than 11%.
2.5. Cell viability and e-juice mediated DNA fragmentation assay
(alkaline gel electrophoresis)
Cell viability was performed using 1.8×108 cells/mL treated with
maximum (1:4 dilution or 2.5 mg/mL) and least minimum (1:64
dilution or 0.156 mg/mL) doses of e-juice amended in PBS solution.
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Details of cell-viability and DNA fragmentation assays are described in
SI section.
3. Results
3.1. UV–Vis spectra of e-juice and solubilized e-juice aerosols
UV–Vis spectra of the dilute e-juice in liquid form as well as bubble-
dissolved SEA produced from the e-cigarette after puﬀed through the
fresh synthetic M9-medium showed a total of ﬁve overlapping peaks
(Fig. 2). Peaks at 254, 260 and 265 nm represent e-juice nicotine in
M9-medium at pH 7.6 consistent to that previously reported (Clayton
et al., 2013). The major peaks at 200–220 nm in both UV-spectra of e-
juice and its SEA seem to have originated due to the additional
chemical ingredients present in e-juice.
3.2. Response of RBCs to e-juice in liquid form
Wild-type and model biosensor cells, such as E. coli-K12 (wild-type,
control), E. coli-RecA (recA::luxCDABE), E. coli-SodA
(sodA::luxCDABE), E. coli-CopA (copA::luxCDABE) and E. coli-
DMO1 (oprF::luxCDABE) responsive to DNA-damage, oxidative
stress, heavy metal and membrane damage, respectively were treated
with standard chemicals, such as mitomycin C (MMC), hydrogen
peroxide (H2O2), copper sulfate (CuSO4) and phenol, respectively
and the results are shown in Fig. S1. All the strains were treated with
varying e-juice concentrations and the results showed a dose-depen-
dent inhibition in bioluminescence signals with EC50=0.71, 0.76, 0.66,
0.25, 0.54 mg/mL nicotine in e-juice, respectively (Fig. S2). Maximum
growth inhibition occurred at 1.25 mg/mL (8-folds diluted) with e-
juice in liquid form, and this trend was reﬂected on their biolumines-
cence responses (Fig. 3a-d). Signiﬁcant increase in bioluminescence
was observed after 60 min interval by all tested biosensor cells,
indicating remarkable stress sensitivity against e-juice. On further
incubation beyond 60 min, except with 2.5 (4-folds diluted) and 1.25
(8-folds diluted) mg/mL, all the biosensor cells exhibited incremental
Fig. 1. (a) Commercial concentrated e-juice/liquid and (b) real image showing a charged e-cigarette device whose mouthpiece connected to an inlet tube immersed in a synthetic M9-
medium in a concentration chamber for sampling SEA. The outlet tube from the chamber opened to empty space in the chamber which is connected to vacuum. The vacuum generates
suction that enables e-vapours to bubble-dissolve in the medium. (c) E. coli promoter regions that regulate recA, sodA, copA and oprF genes are placed upstream of luxCDABE operon in
pDEW201 with ampicillin resistance (bla). (d) A map of promoter-less pDEW201 base plasmid (Lee et al., 2013). (e) The recombinant bacterial cells carrying speciﬁc promoter-
luxCDABE fusion and (f) e-juice and SEA were serially diluted in a 96-well microtiter plate and real-time absorbance and bioluminescence were recorded.
Fig. 2. The UV–Vis absorption spectra of e-juice and solubilized e-juice aerosols (SEA)
in the synthetic-M9 media (pH 7.6) showing overlapping peaks of chemical ingredients.
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Fig. 3. Bioluminescence signals (arbitrary light units, a.u.) generated by recombinant E. coli whole-cell biosensors responsive to speciﬁc toxicity: (a-b) DNA damage (recA::luxCDABE),
(c-d) superoxide radicals (sodA::luxCDABE), (e-f) heavy metals (copA::luxCDABE) and (g-h) membrane damage (oprF::luxCDABE) after the treatment with e-juice (e-liquid) directly
mixed in M9-medium at a series of dilutions shown in ﬁgure legend of (b). The concentrations (mg/mL) in the legend are representatives of the actual nicotine levels present in the
diluted samples. The left column showing bar plots of relative bioluminescence responses from respective biosensor strains carrying speciﬁc promotor-lux fusion (y-axis titles) at a
maximum response time (within 180–270 min). The right column shows time-course bioluminescence responses from 0 to 480 min. The standard errors are shown in shaded areas with
matching colors.
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bioluminescence proﬁles with e-juice dilutions (e-juice: M9=1:16 to
1:256 times dilutions). Furthermore, induction levels in biolumines-
cence (high to low) with respect to e-juice dilutions (0.625–0.039 mg/
mL) after 60 min followed the trend: E.coli-RecA > E.coli-CopA >
E.coli-DMO1 > E.coli-SodA (Fig. 3a-d). This trend was also reﬂected
on the growth of RBCs where growth inhibition is clearly evident with
high e-juice concentrations mixed in M9-medium (Fig. S3a-d, panel I).
These results suggest that the toxicity of e-juice was mainly caused by
the inhibition or blocking of DNA repair mechanism leading to cell
growth inhibition, which is consistent to previously reported studies
(Bahl et al., 2012). Interestingly, E.coli-RecA and E.coli-SodA tend to
induce with a threshold concentration of 0.039 mg/mL (1:256 diluted),
which indicates the potential single-stranded DNA damage and chronic
production of superoxide (O2•−) radicals, respectively. However, E.coli-
CopA strain responsible for inducing to heavy metal toxicity showed
inhibition of bioluminescence response suggesting the possibility that
the selected sub-toxic doses of e-juice may disrupt the cells’ ability to
balance metal ion homeostasis (e.g., copper ions). Therefore, e-juice/
liquid likely to cause the inhibition or damage to copA gene cassette
essential for heavy metal ion pumps. Contrastingly, the bacterial
biosensor E. coli-DMO1 which carries a membrane damage responsive
oprF::luxCDABE fusion was sensitive to even very low e-juice con-
centrations (1:128-256 diluted e-juice or 0.15–0.03 mg/mL nicotine)
suggesting that e-juice can cause detrimental changes in the outer cell
membrane (Fig. 3d).
We observed that the maximum RBCs’ responses to the liquid form
of e-juice tend to decline dose-dependently, but with maximum
response time shifts (MRT) observed from 180 to 240 min after the
exposure. The MRT seem to be associated with the reduction in
number of cells due to growth inhibition. Therefore, cell viability tests
were performed by viable cell counts after treating cells with least
minimum inhibitory (1:64 dilution or 0.156 mg/mL) and maximum
inhibitory (1:4 dilution or 2.5 mg/mL) doses of e-juice amended in PBS
and plated on LB-agar. Fig. S4 shows the viable cells obtained after the
treatment of bacterial cells showing 87–90% and 42–51% inhibition,
respectively compared with the controls (Table S2 and Fig. S4). These
results are consistent with those of bioluminescence signals (repressed
the expression of recA, sodA, copA and oprF promoters) from cells
treated with diluted e-juice in M9 (Fig. 3a-d) and growth inhibition
(Fig. S3a-d, panel I).
3.3. Response of RBCs to solubilized e-juice aerosols (SEA)
SEA was ﬁrst prepared by bubble-dissolving liquid e-juice (1.8 mL
as per the volume for one e-cigarette reﬁll) in M9-medium as described
in experimental methods. Biosensor cells were exposed to a series of
various SEA dilutions (4–256 folds) in M9-medium. Fig. 4a-d show
bioluminescence responses that consistently induced with concen-
trated SEA (SEA: M9=1:4 to 1:32) except E. coli-SodA which showed
highly dynamic bioluminescence induction throughout the course of
SEA exposure (Fig. 4b). Therefore, the prepared dilutions of SEA hold
the potential to induce superoxide (O2•−) radical formation, as evi-
denced by the E. coli-SodA response, unlike the cells treated with e-
juice responded only to the very low doses (Figs. 3a-d and 4a-d). E.
coli-CopA and E. coli-DMO1 cells were highly sensitive to SEA and
exhibited maximum induction levels that can be directly linked to
cellular mitigation against the heavy metal toxicity and membrane/
osmotic stress (Fig. 4c-d). E. coli-CopA responses, however, was
distinct which spontaneously emitted light soon after the SEA expo-
sure, indicating the sensitivity of designed biosensor towards the heavy
metal contamination in the e-juice aerosols. Additionally, E. coli-CopA
also represents the bioluminescence for lower dilutions unlike those
cells treated with e-juice required maximum concentrations, suggesting
the heavy metal speciﬁc stress-response decreases with the dilution of
heavy metal (copper) in the dissolved aerosols (Figs. 3c and 4c). The
above results revealed the dose-dependent genotoxicity and cytotoxi-
city of the dissolved aerosols at such lower concentrations, again
provides an insight into the potential hazards of e-cigarette aerosols,
compared to e-juice alone in liquid form. Remarkably, no reduction in
bioluminescence was observed at higher dilutions of SEA which shows
its non-toxicity to cells. This result was further supported by the growth
studies where cells treated with diﬀerent dilutions of SEA showed no
signiﬁcant diﬀerence in comparison to their respective controls (Fig.
S3, panel II, a-d). However, this observation provides the evidence that
the sensitivity and ability of engineered cells to distinguish or detect the
potential toxicity of e-juice in both liquid and aerosols forms at sub-
toxic levels.
3.4. Cellular DNA fragmentation analysis
We hypothesized that the diﬀerent concentrations of e-juice
potentially cause damage to the total cellular DNA in the model
bacterial biosensor cells and thus showed inhibition of light emission
at high concentrations. This hypothesis was tested with the wild type E.
coli-K12 and four genetically modiﬁed bacterial cells that were nursed
with the 2.5 and 0.156 mg/mL as maximum and least minimum
inhibitory e-juice concentrations, respectively for 2 h in PBS.
Following the treatment, the whole bacterial cells were subjected to
alkaline gel electrophoresis for determining fragmented DNA due to
the damage as described in experimental methods. Fig. 5 shows an
alkaline gel showing two types of DNA bands; (i) the intense bands of
supercoiled genomic DNA tangled or trapped in cells and remain
immobilized in the wells of agarose gel, (ii) fragmented genomic DNA
appeared as smears after the cells present the damaged genomic DNA
from the cells in gel-wells. Cells treated with maximum dose (2.5 mg/
mL or 1:4-folds) of diluted e-juice showed no entrapment of genomic
DNA in the wells because the fragmented DNA running down in the gel
was clearly visible (Fig. 5). The minimum dose (0.156 mg/mL or 1:64-
folds) of dilute e-juice however showed partial DNA fragmentation with
less DNA intensity retained in the wells. These results demonstrated
that high-doses of e-juice in liquid forms induced remarkable DNA
breaks compared to that observed with low-doses or controls.
4. Discussion
E-cigarettes have gained popularity because of their ability to
deliver vaporized nicotine and passive smoking. This has led to
speculation about safety of e-cigarettes due to lack of suﬃcient
evidence on their harmful eﬀects. In this regard, designing and
validation of laboratory models can be used to determine the side
eﬀects or consequences of e-cigarettes in the biological system. To
address this problem, we have used stress-speciﬁc promoters regulat-
ing the lux gene cassette to produce the toxicological evidence against
e-juice in model RBCs as biosensors. Our results revealed that nicotine
amended e-juice inhibits the bioluminescence emission in all bacterial
biosensors at high concentration, while signiﬁcant emission can also be
seen at lower concentrations (Fig. 6a). Contrastingly, the biolumines-
cence proﬁles from the recombinants strains exposed to the diﬀerent
concentrations of SEA showed an opposite eﬀect, where the biolumi-
nescence signal increased dose-dependently (Fig. 6b). The heatmaps in
Fig. 6a-b illustrate an overall response of e-juice in two diﬀerent
physical states (liquid/aerosol) that signiﬁcantly aﬀected the biological
system. The SEA did not aﬀect the cellular growth but strongly induced
genes engaged in mitigating the stress responses (Figs. S3a-d, panel II;
3a-d; 4a-d).
It is well documented that nicotine can induce the production of
ROS which further results into signiﬁcant decrease in the endogenous
antioxidant status of the cell (Muthukumaran et al., 2008).
Additionally, Arany et el. reported the inhibition of superoxide
dismutase, catalase, glutathione peroxidase activities and reduced
glutathione in the cell occurred due to the chronic exposure of nicotine
(Arany et al., 2013). Such eﬀects implicate oxidative stress in cells
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Fig. 4. Bioluminescence signal generated form cells exposed to e-juice vapours (aerosols). The vapours were ﬁrst bubble-dissolved from 1.8 mL e-liquid in 22.5 mL of M9-medium
(equivalent to 1.25 mg/mL nicotine levels). The solubilized e-juice aerosol solution was subjected to treatment with four recombinant E. coli whole-cell biosensors responsive to; (a-b)
DNA damage (recA::luxCDABE), (c-d) superoxide radicals (sodA::luxCDABE), (e-f) heavy metals (copA::luxCDABE) and (g-h) membrane damage (oprF::luxCDABE) at a series of
dilutions shown in ﬁgure legends. The bar plots on left column show relative bioluminescence responses extracted at maximum response times (180–270 min). The right column shows
the time-course bioluminescence proﬁles during 0–480 min and the standard errors are shown in shaded area with matching colors.
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leading to activation of multiple intracellular signaling pathways and
cell death (Ogura and Shimosawa, 2014). We speculate that the toxic
levels of e-juice can damage DNA or inhibit growth through arresting
normal cellular functions, such as ROS defense system. Meanwhile, at
low concentrations, the cells may develop resistance easily in compar-
ison to high concentrations and hence elicit the light emission, except
for E.coli-CopA. This assumption was found true when the biosensor
cells were exposed to 2.5 mg/mL of nicotine in e-juice that showed
signiﬁcant growth loss as evidenced by reduced number of CFU against
0.156 mg/mL concentration (Figs. S2, S4 and Table S2).
Recently, it is documented that the oxidative stress caused by
nicotine is also responsible for inducing DNA damage in epithelial cells
(Ginzkey et al., 2012). Therefore, it was imperative to test the DNA
damage in cells treated with e-juice that had shown signiﬁcant
reduction in growth. Our results revealed that high-doses of e-juice
likely to induce cellular DNA fragmentation at least in bacterial models
(Fig. 6). It remains to be seen if this is also true in human cells. This
result provides early evidence that cell inhibition/death can be possible
at higher doses that seem to occur due to the chemical ingredients/
ﬂavourings present in the e-juice. Furthermore, chemicals known to be
harmful are present in e-cigarette aerosol and their eﬀect could also
depend on several variables, such as the solution used and the battery
output voltage (Bahl et al., 2012; Kosmider et al., 2014). Also, the levels
of toxic product may depend on the way the e-cigarette is used
(Farsalinos et al., 2015).
The heated e-liquid emissions shown to contain the carcinogenic
carbonyl compounds formaldehyde and acetaldehyde (Goniewicz et al.,
2014; Jensen et al., 2015; Kosmider et al., 2014), ROS, heavy metals,
and volatile organic compounds, such as toluene that will have
detrimental eﬀects on living cells (Goniewicz et al., 2014; Lerner
et al., 2015; Williams and Talbot, 2011). In this study, we addressed
these eﬀects with bacterial biosensors that were treated against
diﬀerent dilutions of e-juice and SEA. Our results indicated that the
impact of e-juice at least in bacterial model tend to diminish with
dilutions of chemical ingredients present in e-juice (Figs. 3a-d, 4a-d
and 6a-b). Moreover, the transformation of e-juice into e-vapours by
heat produced more free radicals, which in turn increase the e-vapour
toxicity (Sussan et al., 2015). Hence, E. coli-SodA treated with diﬀerent
dilutions of dissolved e-juice aerosols showed signiﬁcant light emission
when compared with control cells. The E. coli-RecA induced high
bioluminescence emission only at the high doses of SEA probably
because of its ability to oxidatively damage DNA with free O2•−, which
decreased with dilution factor and hence, low bioluminescence emis-
sion from the cells (Fig. 4a). Furthermore, the recombinant E. coli-
CopA showed high bioluminescence at high concentration indicates the
presence of copper in the dissolved aerosols, which reduced in the
media with the dilution. It is to be noted that the contamination of
copper could occur by the oxidation of heating coil in e-cigarette device
as it has been previously reported (Williams et al., 2013).
5. Conclusion
E-cigarettes deliver aerosol containing nicotine to users by heating
e-liquid/juice. Typically, e-juice contains a mixture of glycerin, propy-
lene glycol and various other ﬂavoring chemicals. The potential adverse
eﬀects of a variety of ﬂavoring chemical combinations used in e-juice
Fig. 5. Five E. coli strains (1.8×108 cells/mL) were treated with maximum (2.5 mg/mL
or 1:4 fold) and minimum (0.156 mg/mL or 1:64 fold) inhibitory doses of e-juice liquid
in PBS solution were loaded along with untreated cells on an alkaline agarose gel and
electrophoresed in alkaline buﬀer at 10 V for 14 h. The gel was post-stained with
ethidium bromide after neutralization and the picture was taken under the UV-light. The
fragmented DNA due to high doses of e-juice (yellow arrow highlighted) can be seen as
smears running down the gel. The non-fragmented DNA tangled with cells was seen
trapped in control-wells and low-dose treated cells.
Fig. 6. Heatmaps and clustering of the bioluminescence response data measured at diﬀerent time intervals as shown in x-axis against; (a) e-juice in liquid form mixed in M9-medium,
and (b) Solubilized e-juice aerosol (SEA) in M9-medium. The colors red, black and green represents induction, unchanged or repressed bioluminescence responses from cells against
diﬀerent concentration indicated on y-axis along with strain identities, such as recA (E. coli-RecA), sodA (E. coli-SodA), copA (E. coli-CopA) and oprF (E. coli-DMO1).
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remains largely unexplored. Considering the fastest-growing e-cigar-
ette industry, a rapid and versatile screening method is needed to
assess their toxicant exposure and potential risk to ensure safety.
Herein, we used four stress-speciﬁc recombinant bioluminescent E. coli
cells explicitly respond to single stranded DNA breaks
(recA::luxCDABE), reactive oxygen species (sodA::luxCDABE), heavy
metal such as copper (copA:: luxCDABE) and cell membrane damage
(oprF::luxCDABE). These RBCs provided real-time biological re-
sponses to liquid e-juice and e-cigarette generated SEA in limited
mineral medium with glucose as the only carbon and energy source.
This allowed bioluminescent RBCs to sensitively emit speciﬁc biolu-
minescence light to the e-juice/SEA toxicants. As a result, biolumines-
cent RBCs provided the strong evidences that revealed sub-toxic doses
of e-juice and SEA induce cytotoxicity. We found that the liquid form of
e-juice suppressed the cellular ability to repair DNA damage, ion
homeostasis, oxidative toxicity and membrane disruption caused by the
e-juice. SEA also exhibited toxicity but the level of this toxicity was not
as lethal as it was with the liquid e-juice. Therefore, bioluminescent
RBCs acquired the ability to adapt against the toxicants in SEA by
recruiting inducible cellular repair mechanisms, thus enabling cells to
preserve their normal growth rate and reverse the SEA toxicity.
RBCs served as whole-cell living biosensors to simultaneously
detect both cytotoxicity and intrinsic toxicity mechanisms taking place
against e-juice and SEA. Biological responses from these RBCs can be
used as surrogate responses relevant to human health risk assessments.
However, there is an intrinsic limitation in using multiple RBCs
responsive to distinct type of toxicities and thus diﬀerential biolumi-
nescence patterns, respectively. Therefore, choice of appropriate cell
population size for each RBC type relevant to dose and intensity of
bioluminescence light emission is imperative. Further, real-time toxi-
city monitoring for continuous screening with solubilized e-juice
aerosols from various other e-juice ﬂavoring combinations is required.
Our future directions are toward developing a series of other new
RBCs, each speciﬁc to a diﬀerent type of cytotoxicity that potentially
contribute to a comprehensive understanding on the major cellular
responses against e-juice and SEA. For this, a multi-reactor setting may
be needed that may be equipped to continuously and simultaneously
detect long-term cytotoxicity.
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